| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
37,090,000 |
| Market
Cap: |
22.85(M) |
| Last
Volume: |
1,764,528 |
Avg
Vol: |
1,759,733 |
| 52
Week Range: |
$0.439 - $1.6 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Viracta Therapeutics is a precision oncology company focused on the development of medicines targeting virus-associated malignancies. Co.'s main program is focused on cancers associated with the Epstein-Barr virus (EBV). Co.'s main product candidate is an all-oral combination therapy of its investigational drug, nanatinostat and the antiviral agent valganciclovir (collectively referred to as Nana-val). Nana-val is being investigated in clinical trials, including NAVAL-1, a trial for the treatment of multiple subtypes of relapsed/refractory EBV-positive (EBV+) lymphoma, as well as a trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
100,000 |
100,000 |
| Total Buy Value |
$0 |
$0 |
$49,361 |
$49,361 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
2 |
2 |
| Total Shares Sold |
0 |
3,405 |
10,637 |
44,899 |
| Total Sell Value |
$0 |
$2,493 |
$9,445 |
$116,762 |
| Total People Sold |
0 |
1 |
1 |
3 |
| Total Sell Transactions |
0 |
1 |
3 |
11 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Semon Dominique |
10% Owner |
– – • |
2010-02-25 |
4 |
OE |
$0.22 |
$747,626 |
I/I |
3,398,300 |
3,398,300 |
|
- |
|
| Hurwitz Edward |
Director |
– • • |
2009-12-14 |
4 |
S |
$2.01 |
$4,485,913 |
I/I |
(2,232,464) |
0 |
|
- |
|
| Champsi Farah |
10% Owner |
– – • |
2009-12-14 |
4 |
S |
$2.01 |
$377,193 |
I/I |
(187,714) |
0 |
|
- |
|
| Champsi Farah |
10% Owner |
– – • |
2009-12-14 |
4 |
S |
$2.01 |
$4,108,721 |
D/D |
(2,044,750) |
0 |
|
- |
|
| Semon Dominique |
10% Owner |
– – • |
2009-12-11 |
4 |
S |
$2.02 |
$3,046,263 |
I/I |
(1,508,051) |
0 |
|
- |
|
| Warburg Pincus Llc |
10% Owner |
– – • |
2009-07-21 |
4 |
S |
$0.28 |
$95,709 |
D/D |
(347,655) |
3,204,075 |
|
- |
|
| Warburg Pincus Llc |
10% Owner |
– – • |
2009-07-20 |
4 |
S |
$0.28 |
$30,933 |
D/D |
(110,200) |
3,551,730 |
|
- |
|
| Warburg Pincus Llc |
10% Owner |
– – • |
2009-07-17 |
4 |
S |
$0.30 |
$2,308 |
D/D |
(7,625) |
3,661,930 |
|
- |
|
| Warburg Pincus Llc |
10% Owner |
– – • |
2009-07-14 |
4 |
S |
$0.32 |
$34,390 |
D/D |
(107,300) |
3,846,775 |
|
- |
|
| Warburg Pincus Llc |
10% Owner |
– – • |
2009-07-13 |
4 |
S |
$0.37 |
$130,410 |
D/D |
(350,000) |
3,954,075 |
|
- |
|
| Semon Dominique |
10% Owner |
– – • |
2009-04-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,508,051 |
|
- |
|
| Hurwitz Edward |
Director |
– • • |
2009-04-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,232,464 |
|
- |
|
| Bay City Capital Fund V Co-Investment Fund Lp |
10% Owner |
– – • |
2009-04-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,091 |
|
- |
|
| Misfeldt Dayton |
Director |
– • • |
2009-04-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,091 |
|
- |
|
| Champsi Farah |
10% Owner |
– – • |
2009-04-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
187,714 |
|
- |
|
| Champsi Farah |
10% Owner |
– – • |
2009-04-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,044,750 |
|
- |
|
| Leff Jonathan S |
Director |
– • – |
2007-09-28 |
5 |
A |
$0.00 |
$0 |
I/I |
10 |
4,304,089 |
|
- |
|
| Mcdowell Robert Scott |
Vice President, ResearchOffice |
• – – |
2007-09-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,882 |
|
- |
|
| Leff Jonathan S |
Director |
– • – |
2007-05-30 |
4 |
B |
$4.43 |
$2,999,996 |
I/I |
677,200 |
4,304,075 |
2.1 |
- |
|
| Warburg Pincus Partners Llc |
10% Owner |
– – • |
2007-05-30 |
4 |
B |
$4.43 |
$2,999,996 |
D/D |
677,200 |
4,304,075 |
2.45 |
- |
|
| Swisher Daniel N Jr |
President and CEO |
• • – |
2007-03-21 |
4 |
B |
$4.25 |
$21,340 |
D/D |
5,000 |
34,665 |
2.81 |
- |
|
| Bjerkholt Eric |
Sr. VP, Corp. Dev. & Finance |
• – – |
2007-03-13 |
4/A |
B |
$4.30 |
$12,900 |
D/D |
3,000 |
5,567 |
2.74 |
- |
|
| Bjerkholt Eric |
Sr. VP, Corp. Dev. & Finance |
• – – |
2007-03-13 |
4 |
B |
$4.30 |
$12,900 |
D/D |
3,000 |
3,000 |
2.74 |
- |
|
| Swisher Daniel N Jr |
President and CEO |
• • – |
2006-12-14 |
4 |
B |
$4.15 |
$74,742 |
D/D |
17,900 |
1,900 |
2.81 |
- |
|
| Wells James A |
Director |
– • – |
2006-09-08 |
4 |
AS |
$6.00 |
$30,000 |
D/D |
(5,000) |
318,530 |
|
- |
|
276 Records found
|
|
Page 10 of 12 |
|
|
0.02 (2.98%) 
